AI sleep data could provide one-week early warning of flu and COVID-19
UKHSA study finds sleep app cough data can detect respiratory illness and signal outbreaks early.
These trials are currently recruiting participants in the UK. Always speak to your GP or specialist before contacting a trial team.
The rationale of the roll-over study (ROSY) is to provide continuous access to study treatment for participants who have completed or exited…
This Phase 2b study is designed to evaluate the safety and efficacy of KT-621 in participants with uncontrolled moderate to severe eosinophilic…
This study will investigate whether a structured physical activity promotion programme, delivered alongside standard treatment with tezepelumab, increases objectively measured physical activity…
The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with…
This study aims to see if a co-designed balance training programme called Sport4Steadiness (S4S), is acceptable to people with COPD and if…
This study will evaluate the effect of triple ICS/LAMA/LABA therapy with BGF MDI 320/14.4/9.6 ฮผg on cardiopulmonary outcomes relative to LAMA/LABA therapy…
Salbutamol is a quick-relief (reliever) inhaler used to treat the symptoms of asthma and COPD. It…
Learn more โYour patient insight is valuable. Take a short survey and help researchers improve treatments for Lung & Breathing.
Living with Lung & Breathing? Your experience can help others. Share what you've learned.
Thousands of UK patients are managing Lung & Breathing. Connect, share experiences, and support each other.
The latest pipeline drugs, clinical breakthroughs, and regulatory approvals from the FDA, EMA and NICE for Lung & Breathing patients.
HTG776
TA1142
TA1045
๐ Information sourced from clinical trial registries, FDA, EMA and published research
View all research โNo podcasts available yet for Lung & Breathing
Sign up for updates below to be notified when we release a free patient podcast for this area.